Market Place
Sourcing Support
Dr. Reddy`s Receives EC Approval For AVT03: Biosimilar Launch
24 Nov 2025 //
PRESS RELEASE
Alvotech Gets AVT03, Biosimilar Approval For Prolia And Xgeva
24 Nov 2025 //
GLOBENEWSWIRE
Alvotech USA`s Ustekinumab Receives BLA Approval in US
21 Nov 2025 //
FDA
Alvotech, Advanz Pharma Gain EMA Nod for Gobivaz
20 Nov 2025 //
PHARMIWEB
Alvotech Reports 9-Month 2025 Results & Business Update
12 Nov 2025 //
GLOBENEWSWIRE
Alvotech, Advanz Pharma Secure MHRA Approval For Gobivaz
06 Nov 2025 //
GLOBENEWSWIRE
FDA Issues Form 483 to Alvotech
06 Nov 2025 //
FDA
FDA Issues Form 483 to Alvotech Hf
05 Nov 2025 //
FDA
Alvotech To Webcast Financial Results & Business Update On Nov 13
04 Nov 2025 //
GLOBENEWSWIRE
Alvotech Updates US Biologics License Application For AVT05
02 Nov 2025 //
GLOBENEWSWIRE
Alvotech Restructures Global Biz Development and Commercial Team
22 Oct 2025 //
GLOBENEWSWIRE
EMA Accepts AVT23 Xolair Biosimilar Application From Alvotech
06 Oct 2025 //
GLOBENEWSWIRE
European Medicines Agency Backs Gobivaz® Approval As Simponi®
22 Sep 2025 //
GLOBENEWSWIRE
EMA Recommends Marketing Authorization of AVT03
22 Sep 2025 //
GLOBENEWSWIRE
Alvotech Wins Japan Approval for Three New Biosimilars
19 Sep 2025 //
GLOBENEWSWIRE
Alvotech Engages Investor at Morgan Stanley Healthcare Conference
04 Sep 2025 //
GLOBENEWSWIRE
Advanz Pharma, Alvotech Get EU Approval for Mynzepli
21 Aug 2025 //
GLOBENEWSWIRE
Advanz Pharma & Alvotech Win European Approval for Mynzepli
21 Aug 2025 //
CONTRACTPHARMA
Alvotech Names Patrik Ling as VP of Investor Relations
20 Aug 2025 //
GLOBENEWSWIRE
Alvotech Reports First Half 2025 Results and Business Update
13 Aug 2025 //
GLOBENEWSWIRE
Alvotech to Report First Half 2025 Financial Results in August
06 Aug 2025 //
GLOBENEWSWIRE
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
10 Jul 2025 //
GLOBENEWSWIRE
Alvotech Acquires Ivers-Lee Group
09 Jul 2025 //
GLOBENEWSWIRE
Luxembourg Law Mandates Issuer Transparency Under Article 13
03 Jul 2025 //
GLOBENEWSWIRE
Alvotech and Advanz Pharma Partner for Biosimilar to Cimzia®
01 Jul 2025 //
GLOBENEWSWIRE
Granting of Stock Options and Vesting of Restricted Share Units
01 Jul 2025 //
GLOBENEWSWIRE
Alvotech Lenders Cut Interest on Loan Facility
26 Jun 2025 //
GLOBENEWSWIRE
Main Results of 2025 Annual and Extraordinary General Meeting
25 Jun 2025 //
GLOBENEWSWIRE
Positive Results from Efficacy Study for Biosimilar to Xolair®
25 Jun 2025 //
GLOBENEWSWIRE
EMA Recommends Approval of Alvotech’s Eylea Biosimilar
23 Jun 2025 //
GLOBENEWSWIRE
Alvotech Completes Private Placement with SDRs and Shares
11 Jun 2025 //
GLOBENEWSWIRE
Alvotech`s Private Placement Completed with SDRs and Shares
11 Jun 2025 //
GLOBENEWSWIRE
Alvotech at Goldman Sachs Global Healthcare Conference Miami
06 Jun 2025 //
GLOBENEWSWIRE
Alvotech presents at Goldman Sachs Global Healthcare Conference
06 Jun 2025 //
GLOBENEWSWIRE
Alvotech & Dr. Reddy’s Collab to co-develop Keytruda
05 Jun 2025 //
PRESS RELEASE
Alvotech Plans Private Placement of 7.5 M SDRs and Shares
04 Jun 2025 //
GLOBENEWSWIRE
Alvotech completes private placement, raises SEK 750 million
04 Jun 2025 //
GLOBENEWSWIRE
Alvotech Acquires Xbrane R&D Organization Cimzia Biosimilar
04 Jun 2025 //
GLOBENEWSWIRE
Alvotech Presents at Jefferies Global Healthcare Conference 2025
02 Jun 2025 //
GLOBENEWSWIRE
Alvotech, Advanz Pharma Extend Partnership for 3 More Biosimilars
28 May 2025 //
GLOBENEWSWIRE
Alvotech Annual General Meeting to be held June 25, 2025
26 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
23 May 2025 //
GLOBENEWSWIRE
Alvotech`s Shares Trade on Nasdaq Stockholm Today
19 May 2025 //
GLOBENEWSWIRE
Alvotech Appoints DNB Carnegie for Nasdaq Stockholm Liquidity
19 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
16 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
13 May 2025 //
GLOBENEWSWIRE
Transactions of Managers and Closely Associated Persons
09 May 2025 //
GLOBENEWSWIRE
Alvotech Meets Investors at BofA Securities Healthcare Conference
09 May 2025 //
GLOBENEWSWIRE
Alvotech Publishes Prospectus for Nasdaq Stockholm listing
08 May 2025 //
GLOBENEWSWIRE
US Tariffs on Pharmaceuticals to Have Minimal Impact on Alvotech
07 May 2025 //
GLOBENEWSWIRE
Alvotech Reports Q1 2025 Results and Business Update
07 May 2025 //
GLOBENEWSWIRE
Teva & Alvotech Announce FDA Approval for Selarsdi with Stelara
06 May 2025 //
GLOBENEWSWIRE
Alvotech to Webcast Q1 2025 Financial Results on May 8, 2025
02 May 2025 //
GLOBENEWSWIRE
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
27 Mar 2025 //
GLOBENEWSWIRE
Alvotech Reports Record 2024 Results and Business Update
26 Mar 2025 //
GLOBENEWSWIRE
Alvotech Acquires Xbrane’s R&D in Sweden, Strengthens Biosimilars
20 Mar 2025 //
GLOBENEWSWIRE
Alvotech & Dr. Reddy’s Announce FDA acceptance of BLA for AVT03
19 Mar 2025 //
PRESS RELEASE
Alvotech, Dr. Reddy’s FDA Review For Prolia, Xgeva Biosim
18 Mar 2025 //
BUSINESSWIRE
Alvotech Meets Investors at Barclays Global Healthcare Conference
07 Mar 2025 //
GLOBENEWSWIRE
Alvotech to Report 2024 Financial Results on March 26, 2025
24 Feb 2025 //
GLOBENEWSWIRE
